GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Exact Sciences Corporation (EXAS) [hlAlert]

Rating:
Outperform
EXAS
up 289.29 %

Exact Sciences Corporation (EXAS) rated Outperform by William Blair

Posted on: Tuesday,  Dec 14, 2010  11:25 AM ET by William Blair

William Blair rated Outperform Exact Sciences Corporation (NASDAQ: EXAS) on 12/14/2010, when the stock price was $5.70. Since
then, Exact Sciences Corporation has gained 289.30% as of 01/13/2016's recent price of $22.19.
If you would have followed this William Blair's recommendation on EXAS, you would have gained 289.29% of your investment in 1856 days.

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/14/2010 11:25 AM Buy
None
5.70
as of 12/31/2010
1 Week down  -7.55 %
1 Month up  5.26 %
3 Months   
1 YTD up  5.26 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy